Conditions : Hip Osteoarthritis; Exercise; Hydrotherapy Intervention : Other: Group training Sponsor : Norwegian University of Science and Technology Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2439821; Drug: Placebo Sponsor : Eli Lilly and Company Active, not recruiting - verified August 2011

Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Active, not recruiting - verified March 2011

Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Active, not recruiting - verified March 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2439821; Drug: Placebo Sponsor : Eli Lilly and Company Active, not recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD Sponsor : Hoffmann-La Roche Not yet recruiting - verified July 2011

Condition : Psoriatic Arthritis Interventions : Drug: Apremilast; Drug: • Placebo Sponsor : Celgene Corporation Recruiting - verified June 2011

Condition : Rheumatoid Arthritis Interventions : Drug: Golimumab; Drug: Placebo Sponsors : Centocor, Inc.; Schering-Plough Active, not recruiting - verified July 2011